In an interview with Pharm Exec Associate Editor Don Tracy and Vice President of ESG and Corporate Citizenship Carmen Villar, Gilead Sciences discusses the expected changes in the pharmaceutical industry with the entry of young professionals.
US Pharma and Biotech Summit 2024: Pharma prepares for alpha generation
Leave a Comment